Generic Drug Price-Fixing Antitrust Litigation

This multidistrict litigation represents one of the largest antitrust lawsuits in U.S. history, brought by nearly every state. It alleges that over a dozen generic drug manufacturers engaged in a wide-ranging conspiracy to fix prices and allocate markets for hundreds of common generic medications, from antibiotics to blood pressure pills.

The complaint describes a coordinated effort where competing executives would collude via text messages, phone calls, and at industry events to avoid price competition, agreeing to raise and maintain prices in unison. This alleged collusion forced state healthcare programs, and by extension taxpayers, to overpay by billions of dollars for essential medications. The lawsuit seeks to recover these damages and implement structural reforms to prevent future collusion.